bioAffinity Technologies, Inc.

Stocks

BIAF

US09076W3079

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-24 pm EDT			5-day change	1st Jan Change
0.6599 ^USD	-1.18%		-6.22%	-44.08%

Jul. 22	BioAffinity Technologies and Pictor, Inc. Partner to Develop and Commercialize bioAffinity?s Diagnostics for Asthma and COPD	CI
Jul. 21	BioAffinity Technologies, Inc. - Special Call

Transcript : BioAffinity Technologies, Inc. - Special Call

Published on 06/16/2026 at 09:20 pm EDT - Modified on 06/17/2026 at 12:05 am EDT

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Good evening, and welcome, everyone, to tonight's webinar event. Before we begin, just a few reminders to anyone who is new to the webinar. [Operator

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about bioAffinity Technologies, Inc.

Jul. 22	BioAffinity Technologies and Pictor, Inc. Partner to Develop and Commercialize bioAffinity?s Diagnostics for Asthma and COPD	CI
Jul. 21	BioAffinity Technologies, Inc. - Special Call
Jul. 18	Certain Series B Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
Jul. 18	Certain Options of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
Jul. 18	Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
Jul. 18	Certain Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 19-JUL-2026.	CI
Jun. 22	BioAffinity Technologies Reports Positive Preclinical Findings for Proprietary Gene Silencing Technology Targeting Squamous and Basal Skin Cancer Cells	CI
Jun. 18	BioAffinity Technologies Closes $3.2 Million Public Offering	MT
Jun. 17	BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%	MT
Jun. 16	BioAffinity Technologies, Inc. - Special Call
May. 27	Bioaffinity Technologies Receives Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using Cypath Lung Technology	CI
May. 08	Bioaffinity Technologies Inc - Q1 2026 net loss $3.6 million or $0.81 per share	RE
May. 08	BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 28	Bioaffinity Technologies Collaborates With Brooke Army Medical Center For Pilot Study On Asthma And COPD Diagnostics	CI
Apr. 14	BioAffinity Technologies, Inc. Releases Clinical Case Study Demonstrating Cypath Lung Diagnostic Test Performance	CI